Pseudo-babinski's sign and pseudo-responses;Pseudobabinski y pseudorrespuestas

Revista de Neurologia

Volumn 36, Issue 3, 2003, Pages 299-300

  Leon Sarmiento F E ^a,c   Prada Moreno, L J ^b  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b Instituto Nacional de Medicina Legal y Ciencias Forenses Colombia   (Colombia)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABINSKI REFLEX; DIFFERENTIAL DIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; LETTER; MEDICAL RESEARCH; NEUROLOGICAL COMPLICATION; PSEUDOBABINSKI SIGN; PUBLICATION;

EID: 18844466390     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3603.2002491     Document Type: Letter

References (19)

1. Gómez-Fernández L, Calzada-Sierra DJ. Pseudobabinski. Rev Neurol 2001; 32: 799.
2. Di Trocchio F. Las mentíras de la ciencia. Madrid: Alianza; 1998.
3. Górnez-Fernández L, Calzada-Sierra DJ. Réplica. Reflejo de Babinski, ¡si! Signo de Babinski, ¡no! Rev Neurol 2002; 34: 699-700.
4. Koehler PJ, Bruyn GW, Pearce JMS. Neurological eponyms. N. York: Oxford Univ. Press; 2000.
5. León-Sarmiento FE, Prada LJ. The first sign of Babinski. Neurology 2002; 59: 1067.
6. Carpenter R. Neurofisiología. México: Manual Moderno; 1997.
7. Tellería-Díaz A, Calzada-Sierra DJ. Síndrome de Guillain-Barré. Rev Neurol 2002; 34: 966-76.
8. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
9. León-Sarmiento FE, De Cotes AF. Miastenia grave crónica que simula distrofia muscular en el oriente de Colombia, Rev Neurol 2001; 32: 145-7.
10. Olausson H, Lamarre Y, Backlund H, Morin C, Wallin BG, Starck G, et al. Unmyelinated tactile afferents signal touch and project to insular cortex. Nat Neurosci 2002; 5: 900-4.
11. Acosta MT, Montáñez P, León-Sarmiento FE. Half brain but not half function. Lancet 2002; 360: 643.
12. Calzada-Sierra DJ, Gómez-Fernández L. Paraparesia espástica tropical porHTLV-1. A propósito de un caso. Rev Neurol 2001; 32: 498-500.
13. León-Sarmiento FE, Carpintero M. Retrovirus, micotoxinas, inmunosupresión y neurodegeneración. Rev Neurol 2002; 35: 562-71.
14. Weber F, Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rudel R. A small sodium channel blocking factor in the cerebrospinal fluid is preferentially found in Guillain-Barré syndrome: a combined cell physiological and HPLC study. J Neurol 1999; 246: 955-60.
15. Capello E, Roccataglíata L, Schenone A, Gazzola P, Inglese M, Abbruzzese M, et al. Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders? Eur J Neurol 2000; 7: 223-5.
16. León-Sarmiento FE, Prada U. Reflejo de Babinski, sí; signo de Babinski, no; pseudobabinski, ¡nunca! Rev Neurol 2001; 33: 1200.
17. Waxman SG. Demyelinating diseases-new pathological insights, new therapeutic targets. N Engl J Med 1998; 323-4.
18. Popper KR, Eccles JC. The self and its brain. New York: Heidelberg; 1997.
19. León-S FE, De Castro-Costa CM, Gaffga N. Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. Arq Neuro Psiq 1997; 55: 530-5.